Repozytorium
Wyszukaj
Kolekcje
Inne
Evaluation of podocin in urine in horses using qualitative and quantitative methods.
Autorzy
Rok wydania
2020
Czasopismo
Numer woluminu
15
Strony
e0240586/1-e0240586/22
DOI
10.1371/journal.pone.0240586
Kolekcja
Język
Angielski
Typ publikacji
Artykuł
No sensitive method for diagnosing early kidney dysfunction in horses has been identified so far. Many studies carried out in humans and small animals show that podocin can be useful to diagnose various kidney diseases, mainly affecting the glomeruli. The aim of this study was to perform a qualitative and quantitative analysis of podocin in urine samples obtained from healthy horses, horses with clinical kidney dysfunction and horses at risk of acute kidney injury. The study objectives aimed to assess: (1) whether the selected podocin tryptic peptide for LC-MS-MRM allows for podocin detection in horse; and (2) whether the species-specific ELISA test makes this detection possible as well;, (3) whether the chosen methods are sensitive enough to detect kidney dysfunction and glomerular injury, (4) whether the results of the tests applying both methods correspond with one another, (5) whether the results correlate with the hematological and biochemical data. The signals that may indicate the presence of trypsin fragments of podocin were found in three healthy horses, all the horses diagnosed with kidney dysfunction and half of the animals at risk for acute kidney injury. The concentration of podocin, diagnosed with the ELISA test was as follows: from 0.19 to 1.2 ng/ml in healthy animals, from 0.19 to 20.0 ng/ml in AKI horses, from 0.29 to 5.71 ng/ml in horses at risk for acute kidney injury. The results of both methods corresponded significantly. Podocin may be a potential biomarker of clinical kidney disease in horses and may be used in the detection of glomerular injury. However, its use is limited by the possibility of physiological podocyturia. LC-MS-MRM seems to be a more sensitive method to evaluate the presence of podocin than the ELISA test, whilst selected tryptic peptides of podocin appear to apply to horses. The ELISA test showed greater effectiveness in excluding the disease than in confirming it.
Licencja otwartego dostępu
Licencja na prawach której można swobodnie kopiować, rozprowadzać, zmieniać i remiksować objęty prawem autorskim utwór (Utwór-przedmiot prawa autorskiego) pod warunkiem podania imienia i nazwiska autora utworu pierwotnego oraz źródła pochodzenia utworu.
Pełny tekst licencji: https://creativecommons.org/licenses/by/3.0/pl/legalcode
Adres publiczny
Podobne publikacje
Identyfication of tryptic podocin peptide in the feline urine sediments using LC-MS/MRM method.
Bąchor Remigiusz, Szczepankiewicz Barbara, Pasławska Urszula, Mojsa Karolina, Stefanowicz Piotr, Szewczuk Zbigniew
Evaluation of tryptic podocin peptide in urine sediment using LC-MS-MRM method as a potential biomarker of glomerular injury in dogs with clinical signs of renal and cardiac disorders.
Szczepankiewicz Barbara, Bąchor Remigiusz, Pasławski Robert, Siwińska Natalia, Pasławska Urszula, Konieczny Andrzej, Szewczuk Zbigniew
Detection of podocin in human urine sediment samples by charge derivatization and LC-MS-MRM method.
Bąchor Remigiusz, Gąszczyk Dorota, Panek-Laszczyńska Karolina, Konieczny Andrzej, Witkiewicz Wojciech, Stefanowicz Piotr, Szewczuk Zbigniew